This work is licensed under a
Creative Commons Attribution 4.0 International License
Moritani Y.; Shirai K.; Oi M., Pyrazolo[1, 5-a]pyrimidine compounds as cannabinoid receptor antagonists. PCT Int. Appl. WO patent 2007046548.
Mukaiyama H.; Nishimura T.; Kobayashi S.; Komatsu Y., Bioorg. Med. Chem. 16 (2008) 909-921.
Huang S.; Lin R.; Yu Y.; Lu Y.; Connolly P.; Chiu G.; Li S.; Emanuel S.; Middleton S., Bioorg. Med. Chem. Lett. 17 (2007) 1243-1245.
Saggar S.; Sisko J.; Tucker T.; Tynebor R.; Su D.; Anthony N.; Acoustic alert communication system with enhanced signal to noise. U. S. Patent Appl. 2007021442.
Zhang P.; Pennell M.; Wright J.; Chen W.; Leleti M.; Li Y.; Li L.; Xu Y.; Azaindazole compounds and method of use. PCT Int. Appl. WO Patent 2007002293.
(a) Chiu G.; Li, S.; Connolly P.; Middleton S.; Emanuel S.; Huang S.; Lin R.; Lu Y., 3benzoimidazolyl-pyrazolopyrimidines useful in treatings kinase disorders disubstituted derivatives. PCT Int. Appl. WO patent 2006130673; (b) Dwyer M., et al., Bioorg. Med. Chem. Lett. 17 (2007).
Ghorab M.M., Ismail Z.H., Abdel-Gawad S.M., Aziem A.A., Heteroatom Chem. 15 (2004) 57-62.
Feurer A.; Luithle J.; Wirtz S.; Koenig G.; Stasch J.; Stahl E.; Schreiber R.; Wunder F.; Lang D., Novel 2, 5-disubstituted pyrimidine derivatives. PCT Int. Appl. WO patent 2004009589.
(a) Elnagdi M. H.; Elmoghayar M. R. H.; Elgemeie G. H., Adv. Heterocycl. Chem. 41 (1987).
(a) Simon C.; Constantieux T.; Rodriguez J., Eur. J. Org. Chem. 24 (2004).
(a) Reddy A.C.S.; Narsaiah B.; Venkataratnam R.V., J. Fluorine Chem. 86 (1997).
Chebanov V.A.; Saraev V.E.; Desenko S.M.; Chernenko V.N.; Knyazeva I.V.; Groth U.; Glasnov T.N.; Kappe C. O., J. Org. Chem. 73 (2008) 5110-5118. ( Received 14 October 2014; accepted 31 October 2014 ).